Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-K, Date: 2014-03-31, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: SKBI/20140331/10-K/1/000.htm SEC Original: v372910_10k.htm
TABLE OF CONTENTS Page PART I 3 Item 1. Business 3 Item 1A. Risk Factors 10 Item 1B. Unresolved Staff Comments 20 Item 2. Properties 20 Item 3. Legal Proceedings 22 Item 4. Mine Safety Disclosures 23 PART II 23 Item 5. 23 Item 7. Management’s Discussion and Analysis of Financial Conditions and Results of Operations

---

---

Webplus: SKBI/20140331/10-K/2_EX-23.1/000.htm SEC Original: v372910_ex23-1.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-192657) and Registration Statement on Form S-8 (No. 333-181010) of our report dated March 31, 2014, relating to the consolidated financial statements of Skystar Bio-Pharmaceutical Company and its subsidiaries (collectively the “Company”), which appears in this Annual

---

---

Webplus: SKBI/20140331/10-K/3_EX-31.1/000.htm SEC Original: v372910_ex31-1.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SKBI/20140331/10-K/4_EX-31.2/000.htm SEC Original: v372910_ex31-2.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SKBI/20140331/10-K/5_EX-32.1/000.htm SEC Original: v372910_ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. March 31, 2014 Weibing Lu Chief Executive Officer

---

---

Webplus: SKBI/20140331/10-K/6_EX-32.2/000.htm SEC Original: v372910_ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. March 31, 2014 Bing Mei Chief Financial Officer

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-K, Date: 2014-03-31, XBRL Interactive FinancialsCIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4
XIAN PROVINCE